All Featured Insights

All ACIP committee members dismissed, dozens of states sue 23andMe, FDA to use AI in drug approvals

CBO releases coverage impacts of One Big Beautiful Bill, 5th Circuit to rehear No Surprises Act challenge, many Epic customers live on TEFCA.

RFK Jr. clears Senate panel, federal and state policy battle over transgender care comes to head in New York, Moody’s downgrades health insurer credit outlook

OMB memo causes significant confusion, Change cyberattack affected 190 million people, Cigna to limit out-of-pocket drug costs.

SCOTUS to hear challenge to ACA preventive care mandate, DEA proposes telehealth rule for controlled substances, FDA announces three regulations

CMS finalizes the 2025 OPPS rule, an appeals court rules reverses a No Surprises Act decision, and MACPAC calls for more Medicaid payment oversight.

The FTC finalizes its premerger notification rule, Walgreens announces over 1K closures, and providers win a large antitrust class action settlement.

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation.

CMS releases results from the first round of Medicare Drug Price Negotiations, Steward finds a buyer for its physician group, and employers are using price transparency data in their suits against Aetna.

CVS to roll out co-located Oak Street Health clinics amid reduced profit outlook, CMS finalizes inpatient payment rule that includes new mandatory bundled payment model, and an appeals court gives providers another win in No Surprises Act litigation.

Community Health Systems plans to sell its three Pennsylvania hospitals, a bankruptcy judge allows Steward Health Care to close two Massachusetts hospitals, and CMS approves North Carolina’s medical debt relief program.

The House Oversight Committee criticizes PBM pricing tactics, Humana’s CenterWell plans to open primary care centers at Walmarts, and a federal judge upholds the FTC’s noncompete rule, diverging from a previous district court ruling.